Colony Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-153,720
| Closed | -$7.07M | – | 295 |
|
|
2016
Q3 | $7.07M | Sell |
153,720
-7,070
| -4% | -$325K | 0.79% | 50 |
|
|
2016
Q2 | $8.08M | Buy |
160,790
+4,240
| +3% | +$213K | 0.89% | 46 |
|
|
2016
Q1 | $8.38M | Sell |
156,550
-1,950
| -1% | -$104K | 0.97% | 41 |
|
|
2015
Q4 | $10.4M | Buy |
158,500
+151,588
| +2,193% | +$9.95M | 0.95% | 35 |
|
|
2015
Q3 | $390K | Buy |
6,912
+2,085
| +43% | +$118K | 0.05% | 265 |
|
|
2015
Q2 | $285K | Buy |
4,827
+4,640
| +2,481% | +$274K | 0.03% | 305 |
|
|
2015
Q1 | $12K | Sell |
187
-4,100
| -96% | -$263K | ﹤0.01% | 550 |
|
|
2014
Q4 | $247K | Buy |
4,287
+4,000
| +1,394% | +$230K | 0.03% | 314 |
|
|
2014
Q3 | $15K | Hold |
287
| – | – | ﹤0.01% | 551 |
|
|
2014
Q2 | $15K | Sell |
287
-1,792
| -86% | -$93.7K | ﹤0.01% | 475 |
|
|
2014
Q1 | $110K | Buy |
2,079
+192
| +10% | +$10.2K | 0.01% | 260 |
|
|
2013
Q4 | $76K | Buy |
+1,887
| New | +$76K | 0.01% | 289 |
|